Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Amylyx Pharmaceuticals, Inc. • May 11th, 2023 • Pharmaceutical preparations
This First Amendment to the Supply Agreement (as defined below) ("Amendment") effective as of January 1st, 2023 (the "Amendment Effective Date") is between
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder...Product Agreement • May 11th, 2023 • Amylyx Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment No. 2, is effective as of March 20th, 2023 (“Effective Date”) by and between Amylyx Pharmaceuticals, Inc., having a principal place of business of business at 43 Thorndike Street, Cambridge, MA 02141 (“Client”) and Patheon Inc., having a principal place of businessat 111 Consumers Drive, Whitby, Ontario, L1N 5Z5 (“Patheon”).
